About Samuel Bjork
Form D filings for EpiBiologics in 2024 list Samuel Bjork as director.
Samuel Bjork first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Samuel Bjork in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Samuel Bjork works with at each company, as listed on that company's latest Form D.
EpiBiologics, Inc. · Form D/A, Apr 25, 2024
JC
Jason Coloma
Director
AK
Ann Lee-Karlon
CEO and director
Alexandra Cantley
Director
MM
Mitchell Mutz
Executive officer and director
SM
Seiji Miyahara
Director
JW
James Wells
Director